Edition:
United States

Summit Therapeutics PLC (SMMT.OQ)

SMMT.OQ on NASDAQ Stock Exchange Global Market

1.22USD
13 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.22
Open
$1.25
Day's High
$1.25
Day's Low
$1.21
Volume
4,249
Avg. Vol
16,424
52-wk High
$15.75
52-wk Low
$1.12

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta -- 0.66 0.95
Price to Sales (TTM) -- 242.95 21.76
Price to Book (MRQ) -- 18.87 4.53
Price to Tangible Book (MRQ) -- 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago -- 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) -- 6.87 3.68
LT Debt to Equity (MRQ) -- 16.70 9.53
Total Debt to Equity (MRQ) -- 21.89 13.39
Interest Coverage (TTM) -- -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -- -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -- -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -- -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 28,103,806 878,349,382
Net Income/Employee (TTM) -- -3,710,889 102,474,711
Receivable Turnover (TTM) -- 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) -- 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 0.35 11.06
Return on Assets - 5 Yr. Avg. -- 2.90 11.85
Return on Investment (TTM) -- 0.60 13.80
Return on Investment - 5 Yr. Avg. -- 2.87 15.17
Return on Equity (TTM) -- -2.18 15.29
Return on Equity - 5 Yr. Avg. -- -0.88 16.29

Performance for Summit Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.